This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Adjuvant Combined Radiation and Chemotherapy Following Curative Resection

Martin H. Kaiser, MD; Susan S. Ellenberg, PhD

Arch Surg. 1985;120(8):899-903.

Abstract
• The efficacy of combined radiation and fluorouracil as adjuvant therapy for pancreatic cancer is suggested by a prospective randomized study conducted by the Gastrointestinal Tumor Study Group (GITSG). Twenty-two patients randomized to no adjuvant treatment and 21 to combined therapy were analyzed. Neither life-threatening toxic reaction nor death due to toxic effect was encountered. The study was terminated prematurely because of an unacceptably low rate of accrual combined with the observation of increasingly large survival differences between the study arms. Median survival for the treatment group (20 months) was significantly longer than that observed for the control group (11 months). Four patients, three in the treated and one in the control group, have survived five years or longer following surgery. The extent of the tumor and initial performance status were significantly and independently related to survival.

(Arch Surg 1985;120:899-903)

Author Affiliations
From the University of Miami (Dr Kalser) and the EMMES Corp (Dr Ellenberg), Potomac, Md.

Footnotes
Accepted for publication Dec 12, 1984.

Reprint requests to Gastrointestinal Tumor Study Group Operations Office, EMMES Corp, 11325 Seven Locks Rd, Suite 214, Potomac, MD 20854 (Dr Ellenberg).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Margin Clearance and Outcome in Resected Pancreatic Cancer
Chang et al.
JCO 2009;27:2855-2862.
ABSTRACT | FULL TEXT  

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review
Le Scodan et al.
Ann Oncol 2009;0:mdp015v1-mdp015.
ABSTRACT | FULL TEXT  

Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704
Berger et al.
JCO 2008;26:5918-5922.
ABSTRACT | FULL TEXT  

Adjuvant Therapy for Adenocarcinoma of the Pancreas: Analysis of Reported Trials and Recommendations for Future Progress
Wolff et al.
Ann. Surg. Oncol. 2008;15:2773-2786.
ABSTRACT | FULL TEXT  

Biology and management of pancreatic cancer
Ghaneh et al.
Postgrad. Med. J. 2008;84:478-497.
FULL TEXT  

Past and Future of Pancreas Cancer: Are We Ready to Move Forward Together?
Merchant and Berlin
JCO 2008;26:3478-3480.
FULL TEXT  

Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital
Herman et al.
JCO 2008;26:3503-3510.
ABSTRACT | FULL TEXT  

Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
Corsini et al.
JCO 2008;26:3511-3516.
ABSTRACT | FULL TEXT  

Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head
Heinrich et al.
JCO 2008;26:2526-2531.
ABSTRACT | FULL TEXT  

Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma: A Randomized Controlled Trial
Regine et al.
JAMA 2008;299:1019-1026.
ABSTRACT | FULL TEXT  

Adjuvant Therapy for Surgically Resected Pancreatic Adenocarcinoma
Abbruzzese
JAMA 2008;299:1066-1067.
FULL TEXT  

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial
Small et al.
JCO 2008;26:942-947.
ABSTRACT | FULL TEXT  

Tumor-Node-Metastasis Staging of Pancreatic Adenocarcinoma
Katz et al.
CA Cancer J Clin 2008;0:CA.2007.0012v1-CA.2007.0012.
ABSTRACT | FULL TEXT  

Influence of Resection Margins and Treatment on Survival in Patients With Pancreatic Cancer: Meta-analysis of Randomized Controlled Trials
Butturini et al.
Arch Surg 2008;143:75-83.
ABSTRACT | FULL TEXT  

Biology and management of pancreatic cancer
Ghaneh et al.
Gut 2007;56:1134-1152.
FULL TEXT  

Accuracy of Staging Node-Negative Pancreas Cancer: A Potential Quality Measure
Tomlinson et al.
Arch Surg 2007;142:767-774.
ABSTRACT | FULL TEXT  

A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin
Palmer et al.
Ann. Surg. Oncol. 2007;14:2088-2096.
ABSTRACT | FULL TEXT  

Treatment Options for Hepatobiliary and Pancreatic Cancer
Alberts et al.
Mayo Clin Proc. 2007;82:628-637.
ABSTRACT | FULL TEXT  

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial
Oettle et al.
JAMA 2007;297:267-277.
ABSTRACT | FULL TEXT  

Clinical Results on Intra-arterial Adjuvant Chemotherapy for Prevention of Liver Metastasis Following Curative Resection of Pancreatic Cancer
Hayashibe et al.
Ann. Surg. Oncol. 2007;14:190-194.
ABSTRACT | FULL TEXT  

Evaluation of Preoperative Therapy for Pancreatic Cancer Using a Prognostic Nomogram
White et al.
Ann. Surg. Oncol. 2006;13:1485-1492.
ABSTRACT | FULL TEXT  

A Multicenter Randomized Controlled Trial to Evaluate the Effect of Adjuvant Cisplatin and 5-Fluorouracil Therapy after Curative Resection in Cases of Pancreatic Cancer
Kosuge et al.
Jpn J Clin Oncol 2006;36:159-165.
ABSTRACT | FULL TEXT  

Increased Toxicity With Gefitinib, Capecitabine, and Radiation Therapy in Pancreatic and Rectal Cancer: Phase I Trial Results
Czito et al.
JCO 2006;24:656-662.
ABSTRACT | FULL TEXT  

Additional Information
JAMA 2005;294:E1-E3.
FULL TEXT  

Multimodality Approaches for Pancreatic Cancer
Yang et al.
CA Cancer J Clin 2005;55:352-367.
ABSTRACT | FULL TEXT  

Adjuvant Treatment for Resectable Pancreatic Cancer
Chua and Cunningham
JCO 2005;23:4532-4537.
ABSTRACT | FULL TEXT  

Histological and Molecular Markers for Pancreatic Adenocarcinoma: Can They Help Us Define Which Patients Should Receive It?
Weber
Ann. Surg. Oncol. 2005;12:200-201.
FULL TEXT  

Significance of Histological Response to Preoperative Chemoradiotherapy for Pancreatic Cancer
White et al.
Ann. Surg. Oncol. 2005;12:214-221.
ABSTRACT | FULL TEXT  

Chemotherapy for Pancreatic Cancer
Morris et al.
NEJM 2004;350:2713-2715.
FULL TEXT  

New Chemotherapeutic Advances in Pancreatic, Colorectal, and Gastric Cancers
Diaz-Rubio
The Oncologist 2004;9:282-294.
ABSTRACT | FULL TEXT  

A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Neoptolemos et al.
NEJM 2004;350:1200-1210.
ABSTRACT | FULL TEXT  

Adjuvant Therapy for Pancreatic Cancer -- The Debate Continues
Choti
NEJM 2004;350:1249-1251.
FULL TEXT  

Is Reporting of Recurrence Data Important in Pancreatic Cancer?
Meyers et al.
Ann. Surg. Oncol. 2004;11:304-309.
ABSTRACT | FULL TEXT  

Survival Efficacy of Adjuvant Cytosine-Analogue CS-682 in a Fluorescent Orthotopic Model of Human Pancreatic Cancer
Katz et al.
Cancer Res. 2004;64:1828-1833.
ABSTRACT | FULL TEXT  

Should Adjuvant Therapy Remain the Standard of Care for Patients With Resected Adenocarcinoma of the Pancreas?
Chu et al.
Ann. Surg. Oncol. 2003;10:539-545.
ABSTRACT | FULL TEXT  

Preoperative Predictors of Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasms
Wiesenauer et al.
Arch Surg 2003;138:610-618.
ABSTRACT | FULL TEXT  

Management of pancreatic cancer
DTB 2003;41:36-40.
ABSTRACT | FULL TEXT  

Adjuvant therapy in pancreatic cancer: historical and current perspectives
Neoptolemos et al.
Ann Oncol 2003;14:675-692.
ABSTRACT | FULL TEXT  

Diagnosis, Staging, and Surveillance of Pancreatic Cancer
Tamm et al.
Am. J. Roentgenol. 2003;180:1311-1323.
FULL TEXT  

Localized Adenocarcinoma of the Pancreas: The Rationale for Preoperative Chemoradiation
Wayne et al.
The Oncologist 2002;7:34-45.
ABSTRACT | FULL TEXT  

Neoadjuvant Chemoradiation for Localized Adenocarcinoma of the Pancreas
White et al.
Ann. Surg. Oncol. 2001;8:758-765.
ABSTRACT | FULL TEXT  

Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration
Breslin et al.
Ann. Surg. Oncol. 2001;8:123-132.
ABSTRACT | FULL TEXT  

Improved Survival and Local Control After Intraoperative Radiation Therapy and Postoperative Radiotherapy: A Multivariate Analysis of 46 Patients Undergoing Surgery for Pancreatic Head Cancer
Alfieri et al.
Arch Surg 2001;136:343-347.
ABSTRACT | FULL TEXT  

Preoperative Chemotherapy, Radiotherapy, and Surgical Resection of Locally Advanced Pancreatic Cancer
Wanebo et al.
Arch Surg 2000;135:81-87.
ABSTRACT | FULL TEXT  

In vitro evaluation of the genotoxic and clastogenic potential of photodynamic therapy
Halkiotis et al.
Mutagenesis 1999;14:193-198.
ABSTRACT | FULL TEXT  

Pancreatic Cancer: Local Success and Distant Failure
Ryan and Grossbard
The Oncologist 1998;3:178-188.
ABSTRACT | FULL TEXT  

Is the Long-term Survival Rate Improved by Preoperative Irradiation Prior to Whipple's Procedure for Adenocarcinoma of the Pancreatic Head?
Ishikawa et al.
Arch Surg 1994;129:1075-1080.
ABSTRACT  

Preoperative Chemoradiation and Pancreaticoduodenectomy for Adenocarcinoma of the Pancreas
Evans et al.
Arch Surg 1992;127:1335-1339.
ABSTRACT  

Preoperative Staging and Assessment of Resectability of Pancreatic Cancer
Warshaw et al.
Arch Surg 1990;125:230-233.
ABSTRACT